Zoetis (ZTS) EBIT Margin Growth (1y) (2013 - 2026)

Zoetis (ZTS) EBIT Margin Growth (1y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 304.00
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn -157.00
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -5,330.00
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -650.00
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 8,630.00
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 1,962.00
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 111.00
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn 31.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -157.00
Dec 31, 2025 83.00
Sep 30, 2025 38.00
Jun 30, 2025 225.00
Mar 31, 2025 32.00
Dec 31, 2024 105.00
Sep 30, 2024 166.00
Jun 30, 2024 -151.00
Mar 31, 2024 88.00
Dec 31, 2023 -234.00
Sep 30, 2023 46.00
Jun 30, 2023 245.00
Mar 31, 2023 -449.00
Dec 31, 2022 356.00
Sep 30, 2022 -48.00
Jun 30, 2022 -106.00
Mar 31, 2022 1,449.00
Dec 31, 2021 169.00
Sep 30, 2021 203.00
Jun 30, 2021 1,597.00